Details of the Drug

General Information of Drug (ID: DM5UQA9)

Drug Name
Anti-meso-CAR vector transduced T cells
Indication
Disease Entry ICD 11 Status REF
Endometrial cancer 2C76 Phase 1 [1]
Malignant mesothelioma 2C26.0 Phase 1 [1]
Ovarian cancer 2C73 Phase 1 [1]
Pancreatic cancer 2C10 Phase 1 [1]
Triple negative breast cancer 2C60-2C65 Phase 1 [1]
Drug Type
CAR T Cell Therapy
Cross-matching ID
TTD ID
D0G4GY
Repurposed Drugs (RPD) Click to Jump to the Detailed RPD Information of This Drug

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Mesothelin (MSLN) TT4RXME MSLN_HUMAN CAR-T-Cell-Therapy [1]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 ClinicalTrials.gov (NCT02580747) Treatment of Relapsed and/or Chemotherapy Refractory Advanced Malignancies by CART-meso